OTLC · Oncotelic Therapeutics, Inc. · Documents
$0.02
+0.00 (+4.55%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date of this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$9.15M
Shares
457.51M
Volume · Oct 21
238.26K
Avg daily vol (3M)
312.89K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Oncotelic Therapeutics presented its PDAOAI platform and hepatocellular carcinoma research at Drug Discovery 2026. PDAOAI indexes approximately 29 million PubMed abstracts, while a four-gene mTOR-related signature showed retrospective survival associations that do not establish treatment benefit. | 2026-10-13 | 2026-10-07 | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-04 | 2026-08-03 | |
| 8-K | — | 2026-07-14 | 2026-07-10 | |
| 8-K | — | 2026-07-14 | 2026-07-13 | |
| 8-K | — | 2026-06-29 | 2026-06-23 | |
| 10-Q | — | 2026-05-14 | 2026-03-31 | |
| 8-K | — | 2026-05-05 | 2026-05-01 | |
| 8-K | — | 2026-04-16 | — | |
| 10-K | — | 2026-04-15 | 2025-12-31 | |
| 8-K | — | 2026-04-02 | 2026-03-31 | |
| NT 10-K | — | 2026-03-31 | 2025-12-31 | |
| 8-K | — | 2026-03-30 | 2026-03-24 | |
| 8-K | — | 2026-03-30 | 2026-03-23 | |
| 8-K | — | 2026-01-29 | 2026-01-23 | |
| 8-K | — | 2026-01-26 | 2026-01-22 | |
| 8-K | — | 2026-01-07 | 2026-01-02 | |
| 8-K | — | 2026-01-06 | 2025-12-31 | |
| 8-K | — | 2026-01-06 | 2025-12-31 | |
| 8-K | — | 2025-12-30 | 2025-12-23 | |
| 8-K | — | 2025-12-23 | 2025-12-22 | |
| S-1/A | — | 2025-12-22 | — | |
| 8-K | — | 2025-12-09 | 2025-12-04 | |
| S-1 | — | 2025-11-21 | — | |
| 10-Q | — | 2025-11-17 | 2025-09-30 | |
| NT 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-10-22 | 2025-10-21 | |
| 10-Q | — | 2025-08-13 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | 2025-08-06 | |
| 8-K | — | 2025-08-06 | 2025-07-31 | |
| 10-Q | — | 2025-05-15 | 2025-03-31 | |
| 10-K | — | 2025-04-15 | 2024-12-31 | |
| NT 10-K | — | 2025-03-31 | 2024-12-31 | |
| 8-K | — | 2025-03-25 | 2025-03-23 | |
| 8-K | — | 2025-01-02 | 2024-12-31 | |
| 10-Q | — | 2024-11-19 | 2024-09-30 | |
| NT 10-Q | — | 2024-11-14 | 2024-09-30 | |
| 10-Q | — | 2024-08-14 | 2024-06-30 | |
| 10-Q | — | 2024-05-15 | 2024-03-31 | |
| 8-K | — | 2024-04-29 | 2024-04-26 | |
| 10-K | — | 2024-04-12 | 2023-12-31 | |
| NT 10-K | — | 2024-04-01 | 2023-12-31 | |
| 8-K | — | 2024-02-02 | 2024-01-29 | |
| 10-Q | — | 2023-11-14 | 2023-09-30 | |
| 8-K | — | 2023-10-30 | 2023-10-24 | |
| 8-K | — | 2023-08-23 | 2023-08-21 | |
| 10-Q | — | 2023-08-18 | 2023-06-30 | |
| NT 10-Q | — | 2023-08-15 | 2023-06-30 | |
| 8-K | — | 2023-07-13 | 2023-07-07 | |
| 10-Q | — | 2023-05-22 | 2023-03-31 |
Showing 1–50 of 163 filings